Study of IBI3040 in healthy and overweight or obese adults
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called IBI3040 in healthy adults and in adults who are overweight or obese. It aims to see how the drug affects the body, which may help with weight management. Participants will be monitored closely throughout the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old.
- Have a body mass index (BMI) between 20 and 28 kg/m² for the first part, or between 24 and 40 kg/m² for the second part.
- Weigh at least 50 kg (about 110 lbs).
- Be willing to use effective birth control during the study and for 90 days after the last dose.
- Not have diabetes, pancreatitis, or other significant medical conditions (like heart, liver, or kidney problems).
- Not have used weight-loss drugs or certain other medications within the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a new injectable medication called SHR-1179 to see if it is safe and can help with weight loss. It is a placebo-controlled study, meaning some participants receive the drug and others receive an inactive shot, and no one knows which they get.
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This study tests a new experimental medicine called IBI3042, given as a single dose, to see how safe it is in healthy volunteers. It is an early-phase trial that helps doctors understand if the drug is well-tolerated before testing it in patients.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.